Interpretation of Biomarkers of Bone Metabolism in Children: Impact of Growth Velocity and Body Size in Healthy Children and Chronic Disease

Journal of Pediatrics

Volumn 153, Issue 4, 2008, Pages

  Tuchman, Shamir ^a   Thayu, Meena ^a   Shults, Justine ^b   Zemel, Babette S ^a   Burnham, Jon M ^a,b   Leonard, Mary B ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; BODY SIZE; BONE MATURATION; BONE METABOLISM; BONE MINERAL; CHILD; CHRONIC DISEASE; CONTROLLED STUDY; CROHN DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; GROWTH RATE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PUBERTY;

EID: 51449098837     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2008.04.028     Document Type: Article

References (36)

1. Raisz L.G. Physiology and pathophysiology of bone remodeling. Clin Chem 45 (1999) 1353-1358
2. Black D., Bilezikian J., Ensrud K., Greenspan S., Palermo L., Hue T., et al. One year of alendronate after one year of parathyroid hormone(1-84) for osteoporosis. N Engl J Med 353 (2005) 555-565
3. Garnero P., Darte C., and Delmas P. A model to monitor the efficacy of alendronate treatment in women with osteoporosis using a biochemical marker of bone turnover. Bone 24 (1999) 603-609
4. Cremers S., and Garnero P. Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls. Drugs 66 (2006) 2031-2058
5. Schonau E., and Rauch F. Biochemical markers of bone metabolism. In: Glorieux F. (Ed). Pediatric bone: biology and diseases (2003), Academic Press, San Diego 339-357
6. Szulc P., Seeman E., and Delmas P.D. Biochemical measurements of bone turnover in children and adolescents. Osteoporos Int 11 (2000) 281-294
7. Van Coeverden S., Netelenbos J., De Ridder C., Roos J., Popp-Snijders C., and Delemarre-van de Waal H. Bone metabolism markers and bone mass in healthy pubertal boys and girls. Clin Endocrinol 57 (2002) 107-116
8. Rauchenzauner M., Schmid A., Heinz-Erian P., Kapelari K., Falkensammer G., Griesmacher A., et al. Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years. J Clin Endocrinol Metabol 92 (2007) 443-449
9. Sylvester F.A., Davis P.M., Wyzga N., Hyams J.S., and Lerer T. Are activated T cells regulators of bone metabolism in children with Crohn Disease?. J Pediatr 148 (2006) 461-466
10. Gordon C. Bone loss in children with Crohn disease: evidence of "osteoimmune" alterations. J Pediatr 148 (2006) 429-432
11. Burnham J.M., Shults J., Semeao E., Foster B., Zemel B.S., Stallings V.A., et al. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res 19 (2004) 1961-1968
12. Harpavat M., Greenspan S.L., O'Brien C., Chang C.C., Bowen A., and Keljo D.J. Altered bone mass in children at diagnosis of Crohn disease: a pilot study. J Pediatr Gastroenterol Nutr 40 (2005) 295-300
13. Griffiths A.M., Nguyen P., Smith C., MacMillen J.H., and Sherman P.M. Growth and clinical course of children with Crohn's disease. Gut 34 (1993) 939-943
14. Schall J.I., Semeao E.J., Stallings V.A., and Zemel B.S. Self-assessment of sexual maturity status in children with Crohn's disease. J Pediatr 141 (2002) 223-229
15. Morris N.N., and Udry J.R. Validation of a self-administered instrument to assess stage of adolescent development. J Youth Adolesc (1980) 271-280
16. Tanner J. Growth at adolescence. 2nd ed. (1962), Blackwell Scientific Publication, Oxford
17. Ogden C., Kuczmarski R., Flegal K., Mei Z., Guo S., Wei R., et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109 (2002) 45-60
18. Thayu M., Shults J., Burnham J.M., Zemel B.S., Baldassano R.N., and Leonard M.B. Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn's disease. Inflamm Bowel Dis 13 (2007) 1121-1128
19. Cole T. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 44 (1990) 45-60
20. Cadogan J., Blumsohn A., Barker M.E., and Eastell R. A longitudinal study of bone gain in pubertal girls: anthropometric and biochemical correlates. J Bone Miner Res 13 (1998) 1602-1612
21. Thientz G., Buchs B., Rizzoli R., Slosman D., Clavien H., Sizonenko P., et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 75 (1992) 1060-1065
22. Weaver C., Peacock M., Martin B., McCabe G., Zhao J., Smith D., et al. Quantification of biochemical markers of bone turnover by kinetic measures of bone formation and resorption in young healthy females. J Bone Miner Res 12 (1997) 1714-1720
23. Blumsohn A., Hannon R., Wrate R., Barton J., Al-Dehaimi A., Colwell A., et al. Biochemical markers of bone turnover in girls during puberty. Clin Endocrinol 40 (1994) 663-670
24. Rotteveel J., Schoute E., and Delemarre-van de Waal H. Serum procollagen I carboxyterminal propeptide (PICP) levels through puberty: relationship to height velocity and serum hormone levels. Acta Paediatr 86 (1997) 143-147
25. Tobiume H., Kanzaki S., Hida S., Ono T., Moriwake T., Yamauchi S., et al. Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone(GH) deficiency: a potential marker of bone formation and response to GH therapy. J Clin Endocrinol Metab 82 (1997) 2056-2061
26. Leonard M.B. Glucocorticoid-induced osteoporosis in children: impact of the underlying disease. Pediatrics 119 Suppl 2 (2007) S166-S174
27. Varghese S., Wyzga N., Griffiths A., and Sylvester F. Effects of serum from children with newly diagnosed Crohn disease on primary cultures of rat osteoblasts. J Pediatr Gastroenterol Nutr 35 (2002) 641-648
28. Hyams J., Wyzga N., Kreutzer D., Justinich C., and Gronowicz G. Alterations in bone metabolism in children with inflammatory bowel eisease: an in vitro study. J Pediatr Gastroenterol Nutr 24 (1997) 289-295
29. Kuroki T., Shingu M., Koshihara Y., and Nobunaga M. Effects of cytokines on alkaline phosphatase and osteocalcin production, calcification and calcium release by human ostoblastics cells. Br J Rheumatol 33 (1994) 224-230
30. McClane S., and Rombeau J. Cytokines and inflammatory bowel disease: a review. J Parenter Enteral Nutr 23 (1999) S20-S24
31. Teitelbaum S., and Ross F. Genetic regulation of osteoclast development and function. Nat Rev Genetics 4 (2003) 638-649
32. Miheller P., Muzes G., Zagoni T., Toth M., Racz K., and Tulassay Z. Infliximab therapy improves the bone metabolism in fistulizing Crohn's disease. Dig Dis 24 (2006) 201-206
33. Franchimont N., Putzeys V., Collette J., Vermeire S., Rutgeerts P., De Vos M., et al. Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease. Aliment Pharmacol Ther 20 (2004) 607-614
34. Sylvester F.A., Wyzaga N., Hyams J.S., Davis P.M., Lerer T., Vance K., et al. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease. Inflamm Bowel Dis 13 (2007) 42-50
35. Charles P., Poser J.W., Mosekilde L., and Jensen F.T. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion. J Clin Invest 76 (1985) 2254-2258
36. Eriksen E.F., Charles P., Melsen F., Mosekilde L., Risteli L., and Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res 8 (1993) 127-132